PA
AZN icon

PFG Advisors’s AstraZeneca AZN Stock Holding History

PFG Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$325K Sell
1,713
-127
-7% -$23.9K 0.02% 642
2026
Q1 		$363K Sell
1,840
-277
-13% -$53.4K 0.02% 615
2025
Q4 		$389K Sell
2,117
-748
-26% -$131K 0.02% 577
2025
Q3 		$440K Buy
2,865
+441
+18% +$66.7K 0.02% 587
2025
Q2 		$339K Buy
+2,424
New +$340K 0.02% 497

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

PFG Advisors's AZN Position: Q2 2026 in Review

PFG Advisors reduced its AstraZeneca (AZN) stake by 6.9% in Q2 2026, selling an estimated $23.9K and leaving 1,713 shares worth $325K. The position accounts for 0.02% of the portfolio, ranked #642.

PFG Advisors first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $440K in Q3 2025. 552 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • PFG Advisors held 1,713 shares of AstraZeneca worth $325K as of Q2 2026.
  • PFG Advisors sold 127 AstraZeneca shares in Q2 2026, an estimated $23.9K.
  • AstraZeneca made up 0.02% of PFG Advisors's portfolio in Q2 2026, its #642 holding.
  • PFG Advisors first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • PFG Advisors's AstraZeneca position peaked at $440K in Q3 2025.
  • 552 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.